大江

-1.00 (-0.93%)最後更新 2026-09-11

台灣 · 上櫃 · 生技醫療業

106.50525成交張數12.10本益比1.53股價淨值比5.65%殖利率2026-09-11資料日期

ROE 與 ROA

近四季合計;近十年

每股淨值

元

負債比率

負債總額 / 資產總額

現金流量

單季,億元;自由現金流 = 營業現金流 + 資本支出(負值)

季度	資產總額(億)	母公司權益(億)	負債比率	流動比率	每股淨值	ROE(近四季)	ROA(近四季)	營業現金流(億)	自由現金流(億)
2026Q2	142	77	36.7%	1.70	65.13	14.3%	7.5%	3.1	2.4
2026Q1	143	81	33.8%	1.91	68.75	13.6%	7.3%	3.8	3.6
2025Q4	148	78	38.0%	1.72	66.12	12.0%	6.7%	6.0	-4.0
2025Q3	136	73	36.3%	2.09	61.92	12.4%	6.9%	2.3	1.4
2025Q2	135	68	40.4%	1.83	57.75	11.5%	6.0%	3.0	2.9
2025Q1	139	71	39.2%	1.90	59.78	11.1%	6.0%	3.6	3.2
2024Q4	137	81	30.8%	2.72	68.46	10.4%	6.1%	5.2	3.7
2024Q3	136	79	32.6%	2.51	66.49	9.6%	5.2%	3.0	2.8
2024Q2	141	76	36.8%	1.89	64.57	12.1%	6.4%	2.3	2.0
2024Q1	147	84	31.4%	2.35	71.20	10.3%	5.8%	4.4	4.2
2023Q4	141	82	29.9%	2.40	69.53	11.0%	6.1%	2.2	1.1
2023Q3	157	81	38.1%	1.83	68.39	12.4%	6.5%	6.7	6.5
2023Q2	148	77	37.5%	1.69	64.75	13.5%	6.8%	9.4	9.3
2023Q1	149	83	31.1%	2.10	69.90	9.2%	4.9%	0.8	0.6
2022Q4	151	81	33.3%	1.80	68.56	8.8%	4.8%	5.7	5.4
2022Q3	149	79	34.3%	1.77	66.42	7.8%	4.1%	5.2	5.0
2022Q2	151	75	38.1%	1.62	63.13	9.4%	5.2%	-1.8	-2.1
2022Q1	147	74	41.7%	1.50	62.63	17.3%	9.6%	0.5	-0.0
2021Q4	147	81	37.2%	1.76	68.64	19.8%	11.6%	3.5	2.1
2021Q3	151	78	41.1%	1.49	66.30	24.3%	13.6%	1.5	1.3
2021Q2	134	83	37.3%	1.78	70.26	24.9%	14.7%	8.0	8.0
2021Q1	127	79	37.5%	1.66	66.41	24.8%	15.8%	2.8	2.6
2020Q4	120	75	36.6%	1.61	63.44	25.1%	16.1%	7.3	7.0
2020Q3	114	69	38.6%	1.49	58.75	26.5%	16.2%	7.7	8.0
2020Q2	113	63	44.0%	1.31	53.33	26.3%	14.8%	11.5	11.2
2020Q1	106	70	32.8%	1.96	58.92	26.1%	16.7%	0.4	-0.4
2019Q4	108	71	33.4%	2.01	59.63	31.4%	19.1%	2.7	2.8
2019Q3	108	67	37.7%	1.78	56.55	39.2%	22.6%	6.7	4.6
2019Q2	112	64	42.3%	1.66	62.10	48.9%	26.6%	7.2	8.8
2019Q1	105	65	37.7%	2.00	63.29	43.2%	27.7%	-2.0	-4.3
2018Q4	103	57	43.9%	1.80	55.99	39.4%	23.7%	4.1	4.4
2018Q3	93	49	46.7%	1.81	48.84	33.3%	19.7%	17.3	17.0
2018Q2	75	38	49.4%	2.18	43.36	29.4%	17.1%	11.6	11.5
2018Q1	53	37	30.4%	2.19	42.05	24.7%	18.0%	2.2	2.1
2017Q4	48	34	29.4%	2.22	38.92	23.2%	16.3%	5.1	5.3
2017Q3	44	32	26.6%	2.52	36.42	22.1%	16.0%	3.7	3.6
2017Q2	40	29	25.9%	2.55	38.45	22.2%	16.3%	0.4	0.1
2017Q1	37	29	21.4%	3.27	38.42	20.8%	16.0%	1.0	0.9
2016Q4	39	28	28.7%	2.43	36.61	–	–	1.5	-0.5
2016Q3	37	26	28.0%	2.25	34.63	–	–	4.3	4.2